AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitaglo MSR Forte 50mg/1000mg Tablet

Prescription Icon
Prescription Required

Marketer

Aristo Pharmaceuticals Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Sitaglo MSR Forte 50mg/1000mg Tablet

ForteDia 50mg/1000mg tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, potentially lowering heart attack and stroke risk. ForteDia may be used alone or with other diabetes treatments, achieving optimal results when coupled with a balanced diet and regular physical activity. Dosage is tailored to individual health, blood sugar readings, and existing medications. Consuming it with meals minimizes stomach upset. Consistent daily intake at the same time maximizes effectiveness; discontinuation should only occur under medical guidance. Adherence to the prescribed diet and exercise plan is crucial for effective diabetes control. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, and pharyngitis. Hypoglycemia is a potential risk, especially when used concurrently with insulin or sulfonylureas; patients should be aware of its symptoms and management. This medication isn't universally suitable. Inform your physician of any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption before starting. Pregnant or lactating individuals require medical consultation prior to use. Interactions with other medications are possible; disclose all current medications to ensure safety. Alcohol should be limited due to its hypoglycemic effect. Your doctor will monitor kidney function and blood glucose levels throughout treatment.

Primary Ingredients of Sitaglo MSR Forte 50mg/1000mg Tablet

No text was provided to rephrase. Please provide the text you wish to have rewritten.

Uses of Sitaglo MSR Forte 50mg/1000mg Tablet

Managing type 2 diabetes

Major Benefits of Sitaglo MSR Forte 50mg/1000mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Sitaglo MSR Forte 50mg/1000mg Tablets. Ingest the tablets whole; do not chew, crush, or divide them. Administer this medication with a meal.

Common Side effects of Sitaglo MSR Forte 50mg/1000mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitaglo MSR Forte 50mg/1000mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take the Sitaglo MSR Forte 50mg/1000mg tablet with a meal.

How Sitaglo MSR Forte 50mg/1000mg Tablet works:

Sitaglo MSR Forte 50mg/1000mg tablets combine sitagliptin and metformin to manage blood sugar. Sitagliptin boosts insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitaglo MSR Forte 50mg/1000mg tablets with alcohol is contraindicated due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Sitaglo MSR Forte 50mg/1000mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitaglo MSR Forte 50mg/1000mg tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitaglo MSR Forte 50mg/1000mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. The medication is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Patients with liver impairment should likely avoid Sitaglo MSR Forte 50mg/1000mg tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitaglo MSR Forte 50mg/1000mg Tablet :

Should you forget to take a Sitaglo MSR Forte 50mg/1000mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitaglo MSR Forte 50mg/1000mg Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Sitaglo MSR Forte 50mg/1000mg Tablet

Sitagliptin and Metformin, combined as Sitaglo MSR Forte 50mg/1000mg tablets, manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when used with a healthy diet and exercise. Metformin reduces liver glucose production and improves insulin responsiveness. Sitagliptin's action involves DPP4 enzyme inhibition, boosting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Prolonged consumption of Sitaglo MSR Forte 50mg/1000mg Tablets can indeed lead to Vitamin B12 deficiency. This is due to the medication's impact on Vitamin B12 absorption within the gastrointestinal tract. Consequently, untreated deficiency may manifest as anemia and neurological complications, including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and ataxia. To mitigate these risks, supplemental Vitamin B12 intake, at least annually, has been proposed by some studies.
Sitaglo MSR Forte 50mg/1000mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitaglo MSR Forte 50mg/1000mg Tablet constituent or inactive ingredient should not use this medication. Its administration is contraindicated in individuals experiencing severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaglo MSR Forte 50mg/1000mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Retain this medication within its original, securely sealed container or packaging. Follow the storage guidelines specified on the packaging or label. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and others.
Sitaglo MSR Forte 50mg/1000mg tablets may cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare complication is linked to metformin use and thus contraindicated in individuals with kidney impairment, the elderly, or those who consume substantial alcohol. Symptoms can include muscular discomfort or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal pain, or bradycardia. Should these symptoms arise, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Sitagliptin and Metformin, combined as Sitaglo MSR Forte 50mg/1000mg tablets, manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when coupled with a healthy diet and regular physical activity. Metformin reduces liver glucose production and improves insulin responsiveness. Sitagliptin's action involves DPP4 enzyme inhibition, thus boosting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitaglo MSR Forte 50mg/1000mg tablets may cause common side effects including low blood sugar, taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitaglo MSR Forte 50mg/1000mg Tablet ingredient or additive should not use this medication. This medicine is contraindicated in individuals with significant renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaglo MSR Forte 50mg/1000mg Tablet with alcohol is unsafe and raises the risk of lactic acidosis.
Sitagliptin/metformin tablets (e.g., Sitaglo MSR Forte 50mg/1000mg) can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed metformin-associated lactic acidosis (MALA), this rare adverse effect necessitates caution in patients with impaired kidney function, the elderly, or those who consume significant alcohol. Symptoms may encompass muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal discomfort, or bradycardia. If such symptoms arise, discontinue Sitagliptin/metformin and seek immediate medical attention.
Prolonged use of Sitaglo MSR Forte 50mg/1000mg tablets can indeed lead to vitamin B12 deficiency. This occurs because the medication impairs the body's absorption of vitamin B12 in the gastrointestinal tract. Untreated deficiency may manifest as anemia, neurological complications including paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and ataxia. Preventive strategies proposed by some studies include annual supplemental vitamin B12 intake.
Retain this medication within its original, sealed container. Follow the storage guidelines printed on the packaging. Discard any leftover medication. Ensure it remains inaccessible to children, animals, and others.
Sitagliptin and Metformin, combined as Sitaglo MSR Forte 50mg/1000mg tablets, manage type 2 diabetes mellitus in adults. This treatment enhances blood sugar control when coupled with a healthy diet and regular physical activity. Metformin reduces hepatic glucose production and improves insulin responsiveness. Sitagliptin's action involves DPP4 enzyme inhibition, thereby boosting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitaglo MSR Forte 50mg/1000mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use can result in vitamin B12 deficiency.
Patients with hypersensitivity to Sitaglo MSR Forte 50mg/1000mg Tablet constituents or inactive ingredients should not take this medication. Its use is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaglo MSR Forte 50mg/1000mg tablets with alcohol is unsafe due to a heightened risk of lactic acidosis.
Sitagliptin/Metformin 50mg/1000mg tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare side effect necessitates caution in individuals with kidney impairment, the elderly, or those who consume significant alcohol. Symptoms such as muscle aches, weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, vomiting, abdominal discomfort, or bradycardia warrant immediate cessation of Sitagliptin/Metformin use and prompt medical attention.
Prolonged use of Sitaglo MSR Forte 50mg/1000mg tablets can indeed lead to vitamin B12 deficiency. This medication impairs the body's ability to absorb vitamin B12 from the gastrointestinal tract. Consequently, untreated deficiency may manifest as anemia, neurological complications such as paresthesia (tingling and numbness in extremities), weakness, urinary dysfunction, cognitive changes, and ataxia (impaired coordination and balance). To mitigate these risks, supplemental vitamin B12 is recommended by some experts at least annually.
Retain this medication within its original, securely sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and others.
Sitaglo MSR Forte 50mg/10...
180
MRP 209
13% off